Cargando…

Editorial: Glycoconjugates in vaccines and immunotherapeutics

Detalles Bibliográficos
Autores principales:	Shivatare, Sachin, Sanjiv, Kumar, Kikkeri, Raghavendra, Adamo, Roberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386521/ https://www.ncbi.nlm.nih.gov/pubmed/35990665 http://dx.doi.org/10.3389/fimmu.2022.941474

Ejemplares similares

Glycoconjugate vaccines: classic and novel approaches
por: Adamo, Roberto
Publicado: (2021)

Editorial: Complement and Immunotherapeutics
por: Okrój, Marcin, et al.
Publicado: (2021)

Potential targets for next generation antimicrobial glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2018)

Editorial: Advances in Immunotherapeutic Approaches to Tuberculosis
por: Estrada García, Iris, et al.
Publicado: (2021)

Editorial: Immunotherapeutic and Immunoprophylactic Strategies for Infectious Diseases
por: Sautto, Giuseppe A., et al.
Publicado: (2020)

Editorial: “AAV Gene Therapy: Immunology and Immunotherapeutics”
por: Martinez-Navio, José M., et al.
Publicado: (2021)

Glycoconjugates in Host-Helminth Interactions
por: Prasanphanich, Nina Salinger, et al.
Publicado: (2013)

Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
por: Micoli, Francesca, et al.
Publicado: (2018)

Potentiating pneumococcal glycoconjugate vaccine PCV13 with saponin adjuvant VSA-1
por: Kim, Hyunjung, et al.
Publicado: (2022)

Editorial: The immune escape mechanism and novel immunotherapeutic strategies of leukemia
por: Yu, Kang, et al.
Publicado: (2023)

Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against Salmonella Typhimurium and Salmonella Enteritidis
por: Fiorino, Fabio, et al.
Publicado: (2017)

Editorial: Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications
por: Gustafsson, Kenth, et al.
Publicado: (2020)

Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance
por: Del Bino, Linda, et al.
Publicado: (2022)

Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine
por: Ma, Zhongrui, et al.
Publicado: (2017)

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)

Editorial: Unveiling the tumor microenvironment by machine learning to develop new immunotherapeutic strategies
por: Zheng, Ping, et al.
Publicado: (2023)

Immunomodulatory activity of manganese dioxide nanoparticles: Promising for novel vaccines and immunotherapeutics
por: Huang, Yuhe, et al.
Publicado: (2023)

Immunotherapeutic Potential of Extracellular Vesicles
por: Zhang, Bin, et al.
Publicado: (2014)

Maternal Antibodies Elicited by Immunization With an O- Polysaccharide Glycoconjugate Vaccine Protect Infant Mice Against Lethal Salmonella Typhimurium Infection
por: Baliban, Scott M., et al.
Publicado: (2019)

Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates
por: Barchi, Joseph J.
Publicado: (2022)

In-situ tumor vaccination by percutaneous ablative therapy and its synergy with immunotherapeutics: An update on combination therapy
por: Kim, Nicole J., et al.
Publicado: (2023)

Immunotherapeutic progress and application of bispecific antibody in cancer
por: Kang, Jingyue, et al.
Publicado: (2022)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

TREX1 as a Novel Immunotherapeutic Target
por: Hemphill, Wayne O., et al.
Publicado: (2021)

Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
por: Li, Wenting, et al.
Publicado: (2023)

Sugar–Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2015)

Expanding polysaccharide–protein coupling of glycoconjugate vaccines
por: Berti, Francesco
Publicado: (2022)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development
por: Colombo, Cinzia, et al.
Publicado: (2018)

Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019)

Carriers and Antigens: New Developments in Glycoconjugate Vaccines
por: van der Put, Robert M.F., et al.
Publicado: (2023)

Treg: A Promising Immunotherapeutic Target in Oral Diseases
por: Zhang, Yujing, et al.
Publicado: (2021)

Immunotherapeutic Effects of Different Doses of Mycobacterium tuberculosis ag85a/b DNA Vaccine Delivered by Electroporation
por: Liang, Yan, et al.
Publicado: (2022)

Poly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases
por: Olivera-Ardid, Sara, et al.
Publicado: (2022)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

CD38: A Target for Immunotherapeutic Approaches in Multiple Myeloma
por: Morandi, Fabio, et al.
Publicado: (2018)

Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers
por: Dong, Zhen, et al.
Publicado: (2021)

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs
por: von Gunten, Stephan, et al.
Publicado: (2023)

Editorial: Influenza Virus Vaccines and Immunotherapies
por: Kumar, Arun, et al.
Publicado: (2015)

Recent advances on smart glycoconjugate vaccines in infections and cancer
por: Anderluh, Marko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ouq4958vo176rtuhnkdjdlb2d0